jop-2018-3459-File013 – Supplemental material for Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

Maarten Timmers, Paulien Ravenstijn, Liwen Xi, Gallen Triana-Baltzer, Maura Furey, Sandy Van Hemelryck, Jeike Biewenga, Marc Ceusters, Anindya Bhattacharya, Maarten Van Den Boer, Luc Van Nueten, Peter De Boer
2018 Figshare  
Supplemental material, jop-2018-3459-File013 for Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants by Maarten Timmers, Paulien Ravenstijn, Liwen Xi, Gallen Triana-Baltzer, Maura Furey, Sandy Van Hemelryck, Jeike Biewenga, Marc Ceusters, Anindya Bhattacharya, Maarten van den Boer, Luc van Nueten and Peter de Boer in Journal of Psychopharmacology
doi:10.25384/sage.7146104.v1 fatcat:ha2gtsuzkzgxfetffcszks7npq